Status:

UNKNOWN

Tear Osmolarity Over Time With Artificial Tears

Lead Sponsor:

Hom, Milton M., OD, FAAO

Collaborating Sponsors:

Allergan

Conditions:

Dry Eye

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The effect of artificial tears on tear osmolarity

Detailed Description

Tear osmolarity measures the amount of solutes in the human tear film. The higher the reading, the more likely the patient has dry eyes. Some say it has "potential to be the gold standard" of dry eye ...

Eligibility Criteria

Inclusion

  • Between the ages of 18 and over inclusive. Males or females Any race or ethnic background Patient is in generally good \& stable overall health. Patient likely to comply with study guidelines \& study visits. Informed consent signed. Subjective evaluation of symptom of dryness (SESoD): Score 2 (Mild)
  • \-

Exclusion

  • Corneal refractive surgery within 6 months of this study. Intra-ocular surgery within 6 months or ocular laser surgery within 6 months. Pregnant or lactating women. Ocular pathology (includes glaucoma and cataract), which could impact results and/or place patient at risk.
  • Corneal staining Grade 3 or higher No Restasis for past 3 months Discontinue topical medications for at least 1 week

Key Trial Info

Start Date :

October 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2011

Estimated Enrollment :

48 Patients enrolled

Trial Details

Trial ID

NCT01227226

Start Date

October 1 2010

End Date

March 1 2011

Last Update

February 7 2011

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Milton M. Hom, OD, FAAO.

Azusa, California, United States, 91702